NOVAVAX INC.’S COVID-19 VACCINE 89% EFFECTIVE ON NEW MUTATED VIRUS VERSIONS

Highlights – Novavax Inc.’s COVID-19 vaccine 89% effective on new mutated virus versions. The vaccine’s interim analysis on 62 participants has been done so in Britain. Novavax mentioned that their vaccine is 96% effective against the older COVID-19. The South…